214 related articles for article (PubMed ID: 34735417)
1. Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
Nazareth S; Hayward L; Simmons E; Snir M; Hatchell KE; Rojahn S; Slotnick RN; Nussbaum RL
Obstet Gynecol; 2021 Dec; 138(6):860-870. PubMed ID: 34735417
[TBL] [Abstract][Full Text] [Related]
2. Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.
Wu RR; Orlando LA; Himmel TL; Buchanan AH; Powell KP; Hauser ER; Agbaje AB; Henrich VC; Ginsburg GS
BMC Fam Pract; 2013 Aug; 14():111. PubMed ID: 23915256
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study.
Siglen E; Vetti HH; Augestad M; Steen VM; Lunde Å; Bjorvatn C
J Med Internet Res; 2023 Sep; 25():e46571. PubMed ID: 37656502
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Drohan B; Roche CA; Cusack JC; Hughes KS
Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
[TBL] [Abstract][Full Text] [Related]
5. Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy.
Heald B; Keel E; Marquard J; Burke CA; Kalady MF; Church JM; Liska D; Mankaney G; Hurley K; Eng C
J Med Genet; 2021 Dec; 58(12):807-814. PubMed ID: 33168571
[TBL] [Abstract][Full Text] [Related]
6. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
7. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
[No Abstract] [Full Text] [Related]
9. High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis.
Quinn GP; Pal T; Murphy D; Vadaparampil ST; Kumar A
Genet Med; 2012 Feb; 14(2):191-200. PubMed ID: 22261755
[TBL] [Abstract][Full Text] [Related]
10. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
13. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):e143-e149. PubMed ID: 31764758
[TBL] [Abstract][Full Text] [Related]
15. Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
Sobol H; Bignon YJ; Bonaiti C; Cuisenier J; Lasset C; Lortholary A; Noguès C; Stoppa-Lyonnet D; Eisinger F
Dis Markers; 1999 Oct; 15(1-3):15-29. PubMed ID: 10595246
[TBL] [Abstract][Full Text] [Related]
16. Preventing familial breast and ovarian cancer: major research advances with little implication.
Ziogas DE; Katsios CS; Roukos DH
Womens Health (Lond); 2011 Mar; 7(2):135-8. PubMed ID: 21410338
[No Abstract] [Full Text] [Related]
17. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
[TBL] [Abstract][Full Text] [Related]
18. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
[TBL] [Abstract][Full Text] [Related]
19. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
[TBL] [Abstract][Full Text] [Related]
20. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Roukos DH; Briasoulis E
Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
